Welcome to our dedicated page for Fusion Acquisition II news (Ticker: FSNB-UN), a resource for investors and traders seeking the latest updates and insights on Fusion Acquisition II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Fusion Acquisition II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Fusion Acquisition II's position in the market.
Fusion Acquisition Corp. II (NYSE: FSNB) announced that it received a notice from the NYSE regarding non-compliance with Section 802.01E, due to the late filing of its Annual Report on Form 10-K for 2022. The NYSE's notice does not immediately affect the listing of FSNB's securities. The Company is given until October 17, 2023, to regain compliance by submitting the overdue report. This delay was previously communicated in its Form 12b-25 filed on March 31, 2023, which indicated a need for more time to finalize financial statements. FSNB is actively working on completing the filing and aims to submit the 10-K as soon as possible.
Fusion Acquisition Corp. II (NYSE: FSNB) announced it received a notice from the NYSE for non-compliance due to the delay in filing its Q1 2021 Form 10-Q. The notice does not affect the company's stock listing immediately. The company can regain compliance by filing the report by November 24, 2021. This delay stems from assessing the implications of the SEC statement regarding warrant accounting. Fusion is actively working to complete the filing as soon as possible.
Fusion Acquisition Corp. II (NYSE: FSNB.U) announced that starting April 19, 2021, holders of units from its IPO can separately trade common stock and warrants. The shares will trade under the symbols “FSNB” for common stock and “FSNB WS” for warrants, with non-separated units continuing under “FSNB.U.” No fractional warrants will be issued upon separation, requiring brokers to contact the transfer agent for the process. This follows the SEC's approval of the related registration statement on February 25, 2021.
Fusion Acquisition Corp. II (NYSE: FSNB.U) successfully closed its initial public offering (IPO) on March 2, 2021, raising $500 million from 50 million units priced at $10.00 per unit. The IPO included 6.5 million units from an over-allotment option. Each unit comprises one share of Class A common stock and one-third of a redeemable warrant for stock purchase at $11.50. The proceeds will primarily be placed in a trust. Fusion aims to merge with companies valued between $1.5 billion and $5 billion in fintech or related sectors.
